 Home > Medical News > Latest Medical News > Kelun Pharmaceutical Holdings subsidiary SKB378/HBM9378 injection obtained clinical trial notice

Kelun Pharmaceutical Holdings subsidiary SKB378/HBM9378 injection obtained clinical trial notice

 Last Update: 2022-05-02
 Source: Internet
 Author: User

Tags

claritin drug class

catalyst pharmaceutical

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On February 21, Kelun Pharmaceutical issued an announcement saying that the SKB378/HBM9378 injection jointly developed by its holding subsidiary Kelun Botai and Hebo Pharmaceutical obtained the clinical trial notice from the State Drug Administration, agreeing to carry out moderate-to-severe clinical trials for this product.
Clinical trials in asthma indications
.

SKB378/HBM9378 injection is a class 1 innovative drug with global intellectual property rights jointly developed by Sichuan Kelun Botai Biopharmaceutical Co.
, Ltd.
and Hebo Pharmaceutical using the Hebo medical technology platform H2L2 fully human mouse, targeting TSLP (thymic stromal lymphopoietin, a fully human monoclonal antibody against thymic stromal lymphopoietin), the two parties confirmed that Sichuan Kelun Botai Biopharmaceutical Co.
, Ltd.
and Hebo Pharmaceutical (Shanghai) Co.
, Ltd.
will be the sponsors to promote clinical research
.

As of now, AstraZeneca/Amgen's Tezepelumab is the world's most advanced monoclonal antibody with the same target, which was approved for marketing in the United States on December 17, 2021, and is undergoing Phase III clinical trials in China test
.

Domestic innovative pharmaceutical companies, such as Connoya and Hengrui, have a layout in this target, and no similar products have been approved for marketing in China

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.